Sequencing therapies in oncogene-driven non-small-cell lung cancer: how to get the best mileage?

被引:1
|
作者
Sukrithan, Vineeth [1 ]
Snyder, Rose [2 ]
Cheng, Haiying [1 ]
Halmos, Balazs [1 ]
机构
[1] Albert Einstein Coll Med, Monteflore Med Ctr, Dept Hematol Oncol, 111 E 20th St, Bronx, NY 10467 USA
[2] Albert Einstein Coll Med, Jacobi Med Ctr, Dept Internal Med, 1400 Pelham Pkwy South Bldg 1,Room 3N21, Bronx, NY 10461 USA
关键词
ACQUIRED-RESISTANCE; PATIENT; INHIBITORS;
D O I
10.2217/fon-2019-0103
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:2899 / 2904
页数:6
相关论文
共 50 条
  • [1] Molecularly targeted therapies for oncogene-driven advanced non-small-cell lung cancer
    Okamoto, Isamu
    [J]. CANCER SCIENCE, 2018, 109 : 1224 - 1224
  • [2] Efficacy of immunotherapy in oncogene-driven non-small-cell lung cancer
    Vokes, Natalie I.
    Pan, Kelsey
    Le, Xiuning
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [3] Immune Checkpoint Blockade in Oncogene-Driven Non-Small-Cell Lung Cancer
    Somasundaram, Ashwin
    Socinski, Mark A.
    Villaruz, Liza C.
    [J]. DRUGS, 2020, 80 (09) : 883 - 892
  • [4] Immune Checkpoint Blockade in Oncogene-Driven Non-Small-Cell Lung Cancer
    Ashwin Somasundaram
    Mark A. Socinski
    Liza C. Villaruz
    [J]. Drugs, 2020, 80 : 883 - 892
  • [5] State of the art: oncogene-driven stage IV non-small-cell lung cancer
    Heinzen, Sophie
    Reis, Henning
    Sebastian, Martin
    Demes, Melanie
    Stratmann, Jan
    [J]. ONKOLOGIE, 2022, 28 (12): : 1087 - 1094
  • [6] Treatment of oncogene-driven non-small cell lung cancer
    Kastelijn, Elisabeth A.
    de Langen, Adrianus J.
    Peters, Bas J. M.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2019, 25 (03) : 300 - 307
  • [7] Role of Immunotherapy for Oncogene-Driven Non-Small Cell Lung Cancer
    Miura, Yosuke
    Sunaga, Noriaki
    [J]. CANCERS, 2018, 10 (08)
  • [8] Brain metastases in oncogene-driven non-small cell lung cancer
    Nishino, Makoto
    Soejima, Kenzo
    Mitsudomi, Tetsuya
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S298 - S307
  • [9] Acquired Resistance to Targeted Therapies Against Oncogene-Driven Non-Small-Cell Lung Cancer: Approach to Subtyping Progressive Disease and Clinical Implications
    Gandara, David R.
    Li, Tianhong
    Lara, Primo N.
    Kelly, Karen
    Riess, Jonathan W.
    Redman, Mary W.
    Mack, Philip C.
    [J]. CLINICAL LUNG CANCER, 2014, 15 (01) : 1 - 6
  • [10] Efficacy of immunotherapy in patients with oncogene-driven non-small-cell lung cancer: a systematic review and meta-analysis
    Chen, Jiayan
    Lu, Wanjun
    Chen, Mo
    Cai, Zijing
    Zhan, Ping
    Liu, Xin
    Zhu, Suhua
    Ye, Mingxiang
    Lv, Tangfeng
    Lv, Jiawen
    Song, Yong
    Wang, Dong
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16